April 5, 2024 News by Patricia Inacio, PhD PoNS device made available to US veterans through new collaboration Helius Medical Technologies is collaborating with Lovell Government Services to make its PoNS deviceĀ ā designed to improve walking ability in people withĀ multiple sclerosis (MS) ā available to U.S. veterans and MS patients in other federal healthcare systems. The PoNS device, officially named the Portable Neuromodulation Stimulator, is…
February 9, 2024 News by Mary Chapman Helius to showcase PoNS device at physical therapy meeting Feb. 15-17 Helius Medical Technologies will be showcasing its now-accredited PoNS device ā designed to improve walking ability in people with multiple sclerosis (MS) ā at this year’s American Physical Therapy Association (APTA) Combined Sections Meeting (CMS), slated for Feb. 15-17. The annual meeting, which will feature educational sessions, exhibits,…
March 24, 2023 News by Mary Chapman New deal makes HealthTech Connex exclusive provider of PoNS device An agreement with Helius Medical Technologies has made HealthTech Connex (HTC) the exclusive provider, for at least the next five years, of the noninvasive Portable Neuromodulation Stimulator (PoNS) device in the Vancouver area of British Columbia in Canada. The new deal supplants an earlier clinical research and promotions…
February 17, 2023 News by Mary Chapman Helius provides PoNS device training to physical therapists Helius Medical Technologies will showcase its noninvasive Portable Neuromodulation Stimulator (PoNS) device and provide training to physical therapists who are interested in using the device for the treatment of multiple sclerosis (MS). The company will explain the benefits of PoNS…
January 5, 2023 News by Joana Vindeirinho, PhD PoNS Device Now Available Online to Patients in US People with multiple sclerosis (MS) in the U.S. now may order a Portable Neuromodulation Stimulator (PoNS) device online through a new e-commerce site launched by the deviceās developer, Helius Medical Technologies. The website, built in partnership with the telehealth company UpScript, marks the first time…
October 20, 2022 News by Lindsey Shapiro, PhD Maker of PoNS Device for MS Salutes Physical Therapists For National Physical Therapy Month, Helius Medical TechnologiesĀ is spotlighting physical therapists who make possible the success of the company’s portable neuromodulation stimulator (PONS) device to treat gait problems in people with multiple sclerosis (MS). Helius will broaden access to its free online PoNS training program by enabling…
July 15, 2022 News by Lindsey Shapiro, PhD Helius Offers Online PoNS Training to MS Patients’ Therapists Helius Medical Technologies has launched an online training module for physical therapists who wish to use the company’s Portable Neuromodulation Stimulator (PoNS) device to treat gait deficits in people with multiple sclerosis (MS). The on-demand training modules for healthcare providers in the U.S. are now live, with…
June 9, 2022 News by Marta Figueiredo, PhD PoNS Device Improves Walking Skills Early On, New Data Show Using the portable neuromodulation stimulatorĀ (PoNS) device during a targeted exercise program significantly improves walking skills in people with multiple sclerosisĀ (MS), according to recent real-word data. Notably, significant improvements were observed from the second week onward, and more than half of the 42 patients patients experienced clinically meaningful gains…
April 29, 2022 News by Lindsey Shapiro, PhD PoNS Device for MS-associated Gait Problems Now Available in US The portable neuromodulation stimulator (PoNS) device, which improves walking abilities in people with multiple sclerosis (MS), is now available commercially in the U.S. for patients ages 22 and older who have a prescription from their healthcare provider. The device was approved last year by the U.S. Food…
August 20, 2021 News by Marisa Wexler, MS PoNS Stimulation Device for MS Gait Problems Due in US Next Year PoNS, a non-invasive devise to accompany physical therapy in multiple sclerosis (MS) patients with difficulty walking, will be available on the U.S. market early next year, its developer, Helius Medical Technologies, announced in a quarterly financial update. Short for Portable Neuromodulation Stimulator, the PoNS…
March 29, 2021 News by Marisa Wexler, MS PoNS Device to Help Adults in Rehab for Walking Problems Gets FDA Approval The U.S. Food and Drug Administration (FDA) has authorized the use of a medical device called Portable Neuromodulation StimulatorĀ or PoNS as a short-term treatment for walking difficulties in people with multiple sclerosis (MS). PoNS, developed by Helius Medical Technologies, is a non-invasive medical device…
January 12, 2021 News by Marisa Wexler, MS Helius Provides More Information to FDA About PoNS Device Helius Medical Technologies has submitted its response to the U.S. Food and Drug Administration (FDA)’s request for more information about the company’s application for de novoĀ classification and clearance of its portable neuromodulation stimulator (PoNS) device to help treat walking difficulties in people…
October 16, 2020 News by Joana Carvalho, PhD Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device Helius Medical TechnologiesĀ partnered withĀ Breakthrough HealthĀ on a project focused on understanding how people with multiple sclerosis (MS) in the U.S. evaluate the therapies at their disposal in terms of how well they help their ability to walk. The collaboration will take advantage of an MS companion application, called…
August 17, 2020 Columns by Ed Tobias MS News That Caught My Eye Last Week: Ofatumumab, Aubagio, Oral DMTs, PoNS Device Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials Ofatumumab is a cancer medication that’s awaiting approval by the U.S. Food and Drug Administration and the European Medicines Agency to treat MS patients. It’s delivered by injection once a month and aims to reduce…
August 14, 2020 Columns by Ed Tobias Could a Tongue Stimulator Help to Improve Your Walking? The idea doesn’t seem very appealing to me, but a company is seeking approval from the U.S. Food and Drug Administration (FDA) for a product that might help people with MS walk better by mildly stimulating the tongue. The portable neuromodulation stimulator (PoNS) is a flat…
August 11, 2020 News by InĆŖs Martins, PhD PoNS Device Under Review by FDA for Treating Walking Problems in MS Helius Medical Technologies has filed an application with the U.S. Food and Drug Administration (FDA) asking for de novo classification and clearance of itsĀ portable neuromodulation stimulator (PoNS) device for the treatment of walking deficits in multiple…
May 14, 2020 News by Joana Carvalho, PhD FDA Grants Breakthrough Device Designation to Helius’ PoNS Device The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Helius Medical Technologiesā portable neuromodulation stimulator (PoNS) for the treatment of walking impairments in multiple sclerosis (MS) patients. The device, which is meant to be used…
March 26, 2020 News by Vanessa Pataia Helius Medical Technologies Authorized by Health Canada to Market PoNS Device The neurotechnology company Helius Medical TechnologiesĀ has received authorization from Health CanadaĀ to market its portable neuromodulation stimulator (PoNS) device to treat gait deficit in patients with mild-to-moderate multiple sclerosis…
February 13, 2017 News by Patricia Silva, PhD Tongue Stimulation Could Give MS Patients Better Rehabilitation Outcomes, Study Suggests Multiple sclerosis (MS) patients given gentleĀ electrical stimulation to their tongues during physical and cognitive rehabilitation training benefited more than those who did not have the stimulation,Ā a small pilot study demonstrated. Those who received the weak stimulation had significant improvements in balance and better scores than controls in cognition and other…
October 31, 2016 News by Patricia Silva, PhD PoNS Tongue Stimulator, Designed to Ease Neuroplasticity, Recommended for ISO Certification Helius Medical Technologies‘s Portable Neuromodulation Stimulator (PoNS), a device being developedĀ to treatĀ neuroplasticity in people with multiple sclerosis (MS) and other neurological diseases, has been recommended forĀ ISO 13485 certification, an international standard of quality management for medical devices, after a positive evaluationĀ byĀ Lloydās Register Quality Assurance Limited (LRQA). This…
June 24, 2016 News by InĆŖs Martins, PhD Study Finds PoNS Neurostimulator Plus Physical Therapy of Benefit to Advanced MS Patients Helius Medical Technologies announced results of a pilot study, demonstrating the benefits ofĀ PoNS Therapy ā aĀ combination of the investigational Portable Neuromodulation Stimulator (PoNS) device with physical therapy ā in patients with advanced multiple sclerosis (MS). Specifically, the treatmentĀ was seen to improve both patients’ quality of life, andĀ physical and…
June 19, 2014 News by Charles Moore Increased R&D Focus On PoNS Neuromodulation Therapy Device For People With MS; Other Neurological Conditions Newtown, Pennsylvania based Helius Medical Technologies, Inc. announced on June 6th that the company has entered into an agreement and plan of merger whereby the Company has agreed to acquire 100% of issued and outstanding common shares of Neurohabilitation Corporation (“Neuro”) of Delaware by way of a plan of…